Trial Profile
A Phase Ib Double-blind, Placebo-controlled, Randomized, Dose-escalating Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Repeated Subcutaneous Injections of MT203 in Patients With Mild to Moderate Rheumatoid Arthritis on Treatment With Methotrexate.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Namilumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Acronyms PRIORA
- Sponsors Takeda
- 19 Aug 2015 The number of treatment arms have been changed from 2 to 3 as reported by ClinicalTrials.gov record.
- 13 Jun 2015 Results (safety and tolerability) presented at the 16th Annual Congress of the European League Against Rheumatism.
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.